{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:03Z","timestamp":1794047403645,"version":"4.8.0"},"reference-count":52,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"8","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>High-grade B-cell lymphoma accompanied with double\/triple-hit MYC and BCL2 and\/or BCL6 rearrangements (HGBLDH\/ TH) poses a cytogenetically-defined provisional entity among aggressive B-cell lymphomas that is traditionally associated with unfavorable prognosis. In order to better understand the mutational and molecular landscape of HGBLDH\/ TH we here performed whole-exome sequencing and deep panel next-generation sequencing of 47 clinically annotated cases. Oncogenic drivers, mutational signatures and perturbed pathways were compared with data from follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL). We find an accumulation of oncogenic mutations in NOTCH, IL6\/JAK\/STAT and NF\u03baB signaling pathways and delineate the mutational relationship within the continuum between FL\/DLBCL, HGBL-DH\/TH and BL. Further, we provide evidence of a molecular divergence between BCL2 and BCL6 rearranged HGBL-DH. Beyond a significant congruency with the C3\/EZB DLBCL cluster in BCL2 rearranged cases on an exome-wide level, we observe an enrichment of the SBS6 mutation signature in BCL6 rearranged cases. Differential gene set enrichment and subsequent network propagation analysis according to cytogenetically defined subgroups revealed an impairment of TP53 and MYC pathway signaling in BCL2 rearranged cases, whereas BCL6 rearranged cases lacked this enrichment, but instead showed impairment of E2F targets. Intriguingly, HGBL-TH displayed intermediate mutational features considering all three aspects. This study elucidates a recurrent pattern of mutational events driving FL into MYC-driven BCL2-rearranged HGBL, unveiling the mutational pathogenesis of this provisional entity. Through this refinement of the molecular taxonomy for aggressive, germinal center-derived B-cell lymphomas, this calls into question the current World Health Organization classification system, especially regarding the status of MYC\/BCL6- rearranged HGBL.<\/jats:p>","DOI":"10.3324\/haematol.2021.279631","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T04:03:50Z","timestamp":1637208230000},"page":"1850-1863","source":"Crossref","is-referenced-by-count":45,"title":["Mutational landscape of high-grade B-cell lymphoma with &lt;i&gt;MYC-&lt;\/i&gt;, &lt;i&gt;BCL2&lt;\/i&gt; and\/or &lt;i&gt;BCL6&lt;\/i&gt; rearrangements characterized by whole-exome sequencing"],"prefix":"10.3324","volume":"107","author":[{"given":"Axel","family":"K\u00fcnstner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno M.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"St\u00f6lting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Olschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Ketzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannik","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Trojok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas von","family":"Bubnoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hauke","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred C.","family":"Feller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Gebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"38486","unstructured":"Swerdlow SH, Campo E, Harris NL. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Vol. 2. Lyon: IARC. 2017;586."},{"key":"38487","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Bens S, Advani R. Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol. 2019; 37(35):3359-3368.","DOI":"10.1200\/JCO.19.00743"},{"key":"38488","doi-asserted-by":"crossref","unstructured":"Aukema SM, Kreuz M, Kohler CW. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma. Haematologica. 2014; 99(4):726-735.","DOI":"10.3324\/haematol.2013.091827"},{"key":"38489","doi-asserted-by":"crossref","unstructured":"Aukema SM, Siebert R, Schuuring E. Double-hit B-cell lymphomas. Blood. 2011; 117(8):2319-2331.","DOI":"10.1182\/blood-2010-09-297879"},{"key":"38490","doi-asserted-by":"crossref","unstructured":"Copie-Bergman C, Cuilliere-Dartigues P, Baia M. MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study. Blood. 2015; 126(22):2466-2474.","DOI":"10.1182\/blood-2015-05-647602"},{"key":"38491","doi-asserted-by":"crossref","unstructured":"Oki Y, Noorani M, Lin P. Double hit lymphoma: the MD Anderson Cancer Center clinical experience. Br J Haematol. 2014; 166(6):891-901.","DOI":"10.1111\/bjh.12982"},{"key":"38492","doi-asserted-by":"crossref","unstructured":"Pedersen MO, Gang AO, Poulsen TS. MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC\/BCL2 translocations. Eur J Haematol. 2014; 92(1):42-48.","DOI":"10.1111\/ejh.12212"},{"key":"38493","doi-asserted-by":"crossref","unstructured":"Petrich AM, Nabhan C, Smith SM. MYC-associated and doublehit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches. Cancer. 2014; 120(24):3884-3895.","DOI":"10.1002\/cncr.28899"},{"key":"38494","doi-asserted-by":"crossref","unstructured":"Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Am J Surg Pathol. 2013; 37(3):323-332.","DOI":"10.1097\/PAS.0b013e31826cebad"},{"key":"38495","doi-asserted-by":"crossref","unstructured":"Sarkozy C, Traverse-Glehen A, Coiffier B. Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. Lancet Oncol. 2015; 16(15):e555-567.","DOI":"10.1016\/S1470-2045(15)00005-4"},{"key":"38496","doi-asserted-by":"crossref","unstructured":"Wang XJ, Medeiros LJ, Lin P. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC\/BCL2 protein double-positive diffuse large B-cell lymphoma. Am J Surg Pathol. 2015; 39(9):1250-1258.","DOI":"10.1097\/PAS.0000000000000433"},{"key":"38497","doi-asserted-by":"crossref","unstructured":"Gebauer N, Bernard V, Gebauer W. TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations. Leuk Lymphoma. 2015; 56(1):179-185.","DOI":"10.3109\/10428194.2014.907896"},{"key":"38498","doi-asserted-by":"crossref","unstructured":"Schiefer AI, Kornauth C, Simonitsch-Klupp I. Impact of single or combined genomic alterations of TP53, MYC, and BCL2 on survival of patients with diffuse large B-cell lymphomas: a retrospective cohort study. Medicine (Baltimore). 2015; 94(52):e2388.","DOI":"10.1097\/MD.0000000000002388"},{"key":"38499","doi-asserted-by":"crossref","unstructured":"Evrard SM, Pericart S, Grand D. Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements. Haematologica. 2019; 104(4):e154-e157.","DOI":"10.3324\/haematol.2018.198572"},{"key":"38500","doi-asserted-by":"crossref","unstructured":"Stengel A, Kern W, Meggendorfer M, Haferlach T, Haferlach C. Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements. Br J Haematol. 2019; 185(5):951-954.","DOI":"10.1111\/bjh.15653"},{"key":"38501","doi-asserted-by":"crossref","unstructured":"Momose S, Weissbach S, Pischimarov J. The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum. Leukemia. 2015; 29(8):1789-1791.","DOI":"10.1038\/leu.2015.34"},{"key":"38502","doi-asserted-by":"crossref","unstructured":"Cucco F, Barrans S, Sha C. Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC\/BCL2 double-hit. Leukemia. 2020; 34(5):1329-1341.","DOI":"10.1038\/s41375-019-0691-6"},{"key":"38503","doi-asserted-by":"crossref","unstructured":"Pedersen BS, Quinlan AR. Mosdepth: quick coverage calculation for genomes and exomes. Bioinformatics. 2018; 34(5):867-868.","DOI":"10.1093\/bioinformatics\/btx699"},{"key":"38504","doi-asserted-by":"crossref","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018; 34(17):i884-i890.","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"38505","unstructured":"Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. 2013. Publisher Full Text|"},{"key":"38506","doi-asserted-by":"crossref","unstructured":"McKenna A, Hanna M, Banks E. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-1303.","DOI":"10.1101\/gr.107524.110"},{"key":"38507","doi-asserted-by":"crossref","unstructured":"Boeva V, Popova T, Bleakley K. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics. 2012; 28(3):423-425.","DOI":"10.1093\/bioinformatics\/btr670"},{"key":"38508","doi-asserted-by":"crossref","unstructured":"Chapuy B, Stewart C, Dunford AJ. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018; 24(5):679-690.","DOI":"10.1038\/s41591-018-0016-8"},{"key":"38509","doi-asserted-by":"crossref","unstructured":"Wright GW, Huang DW, Phelan JD. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020; 37(4):551-568.e14.","DOI":"10.1016\/j.ccell.2020.03.015"},{"key":"38510","doi-asserted-by":"crossref","unstructured":"Lawrence MS, Stojanov P, Polak P. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013; 499(7457):214-218.","DOI":"10.1038\/nature12213"},{"key":"38511","doi-asserted-by":"crossref","unstructured":"Chapuy B, Stewart C, Dunford AJ. Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade. Blood. 2019; 134(26):2369-2382.","DOI":"10.1182\/blood.2019002067"},{"key":"38512","doi-asserted-by":"crossref","unstructured":"Mermel CH, Schumacher SE, Hill B. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011; 12(4)","DOI":"10.1186\/gb-2011-12-4-r41"},{"key":"38513","doi-asserted-by":"crossref","unstructured":"Brescia P, Schneider C, Holmes AB. MEF2B instructs germinal center development and acts as an oncogene in B cell lymphomagenesis. Cancer Cell. 2018; 34(3):453-465.","DOI":"10.1016\/j.ccell.2018.08.006"},{"key":"38514","doi-asserted-by":"crossref","unstructured":"Edginton-White B, Cauchy P, Assi SA. Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma. Leukemia. 2019; 33(6):1463-1474.","DOI":"10.1038\/s41375-018-0311-x"},{"key":"38515","doi-asserted-by":"crossref","unstructured":"Lamprecht B, Walter K, Kreher S. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med. 2010; 16(5):571-9.","DOI":"10.1038\/nm.2129"},{"key":"38516","doi-asserted-by":"crossref","unstructured":"Pon JR, Wong J, Saberi S. MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation. Nat Commun. 2015; 6:7953.","DOI":"10.1038\/ncomms8953"},{"key":"38517","doi-asserted-by":"crossref","unstructured":"Love C, Sun Z, Jima D. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012; 44(12):1321-1325.","DOI":"10.1038\/ng.2468"},{"key":"38518","doi-asserted-by":"crossref","unstructured":"Dunleavy K, Little RF, Wilson WH. Update on Burkitt lymphoma. Hematol Oncol Clin North Am. 2016; 30(6):1333-1343.","DOI":"10.1016\/j.hoc.2016.07.009"},{"key":"38519","doi-asserted-by":"crossref","unstructured":"Ma MCJ, Tadros S, Bouska A. Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma. Haematologica. 2022; 107(3):690-701.","DOI":"10.3324\/haematol.2020.274258"},{"key":"38520","unstructured":"Reddy A, Zhang J, Davis NS. Genetic and functional drivers of diffuse large B cell lymphoma. Cell. 2017; 171(2):481-494.e15."},{"key":"38521","doi-asserted-by":"crossref","unstructured":"Meriranta L, Pasanen A, Louhimo R. Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma. Haematologica. 2017; 102(5):e195-e198.","DOI":"10.3324\/haematol.2016.157495"},{"key":"38522","doi-asserted-by":"crossref","unstructured":"Liu Z, Filip I, Gomez K. Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway. Blood Cancer Discov. 2020; 1(1):112-125.","DOI":"10.1158\/2643-3230.BCD-20-0051"},{"key":"38523","doi-asserted-by":"crossref","unstructured":"Cinar M, Rong HR, Chineke I. Genetic analysis of plasmablastic lymphomas in HIV (+) patients reveals novel driver regulators of the noncanonical NF-\u03baB pathway. Blood. 2018; 132(Suppl 1):S1565.","DOI":"10.1182\/blood-2018-99-118351"},{"key":"38524","doi-asserted-by":"crossref","unstructured":"Schmitz R, Young RM, Ceribelli M. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012; 490(7418):116-120.","DOI":"10.1038\/nature11378"},{"key":"38525","doi-asserted-by":"crossref","unstructured":"Landau DA, Tausch E, Taylor-Weiner AN. Mutations driving CLL and their evolution in progression and relapse. Nature. 2015; 526(7574):525-530.","DOI":"10.1038\/nature15395"},{"key":"38526","doi-asserted-by":"crossref","unstructured":"Gonzalez-Rincon J, Mendez M, Gomez S. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma. PLoS One. 2019; 14(2):e0212813.","DOI":"10.1371\/journal.pone.0212813"},{"key":"38527","doi-asserted-by":"crossref","unstructured":"Pedrosa L, Fernandez-Miranda I, Perez-Callejo D. Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. Sci Rep. 2021; 11(1):1886.","DOI":"10.1038\/s41598-020-80376-0"},{"key":"38528","doi-asserted-by":"crossref","unstructured":"Clipson A, Barrans S, Zeng N. The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit. J Pathol Clin Res. 2015; 1(3):125-133.","DOI":"10.1002\/cjp2.10"},{"key":"38529","doi-asserted-by":"crossref","unstructured":"Gu X, Booth CJ, Liu Z, Strout MP. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma. Blood. 2016; 127(1):102-112.","DOI":"10.1182\/blood-2015-02-628164"},{"key":"38530","doi-asserted-by":"crossref","unstructured":"Ye H, Remstein ED, Bacon CM. Chromosomal translocations involving BCL6 in MALT lymphoma. Haematologica. 2008; 93(1):145-146.","DOI":"10.3324\/haematol.11927"},{"key":"38531","doi-asserted-by":"crossref","unstructured":"Nann D, Ramis-Zaldivar JE, Muller I. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. Blood Adv. 2020; 4(22):5652-5665.","DOI":"10.1182\/bloodadvances.2020002944"},{"key":"38532","doi-asserted-by":"crossref","unstructured":"Petljak M, Alexandrov LB, Brammeld JS. Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC mutagenesis. Cell. 2019; 176(6):1282-1294.","DOI":"10.1016\/j.cell.2019.02.012"},{"key":"38533","doi-asserted-by":"crossref","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC. Signatures of mutational processes in human cancer. Nature. 2013; 500(7463):415-421.","DOI":"10.1038\/nature12477"},{"key":"38534","doi-asserted-by":"crossref","unstructured":"Zhang J, Shi Y, Zhao M, Hu H, Huang H. Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy. Sci Rep. 2020; 10(1):14164.","DOI":"10.1038\/s41598-020-71058-y"},{"key":"38535","doi-asserted-by":"crossref","unstructured":"Kotani A, Kakazu N, Tsuruyama T. Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice. Proc Natl Acad Sci U S A. 2007; 104(5):1616-1620.","DOI":"10.1073\/pnas.0610732104"},{"key":"38536","doi-asserted-by":"crossref","unstructured":"Schuhmacher B, Bein J, Rausch T. JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell\/histiocyte-rich large B-cell lymphoma. Haematologica. 2019; 104(2):330-337.","DOI":"10.3324\/haematol.2018.203224"},{"key":"38537","doi-asserted-by":"crossref","unstructured":"Kridel R, Chan FC, Mottok A. Histological transformation and progression in follicular lymphoma: a clonal evolution study. PLoS Med. 2016; 13(12):e1002197.","DOI":"10.1371\/journal.pmed.1002197"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.279631\/73859","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.279631\/74679","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10454\/73859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:00:38Z","timestamp":1794045638000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2021.279631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2021.279631","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.13.21260465","asserted-by":"object"}]},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,18]]}}}